Tema Oncology ETF (CANC) Short Interest Ratio & Short Volume $25.16 +0.34 (+1.37%) As of 03:59 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrends Tema Oncology ETF Short Interest DataTema Oncology ETF (CANC) has a short interest of 6,500 shares. This marks a 195.45% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.2, indicating that it would take 1.2 days of the average trading volume of 45,779 shares to cover all short positions.Current Short Interest6,500 sharesPrevious Short Interest2,200 sharesChange Vs. Previous Month+195.45%Dollar Volume Sold Short$163,670.00Short Interest Ratio1.2 Days to CoverLast Record DateDecember 15, 2024Outstanding Shares1,930,000 sharesPercentage of Shares Shorted0.34%Today's Trading Volume126,715 sharesAverage Trading Volume45,779 sharesToday's Volume Vs. Average277% Short Selling Tema Oncology ETF? Sign up to receive the latest short interest report for Tema Oncology ETF and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCANC Short Interest Over TimeCANC Days to Cover Over TimeCANC Percentage of Float Shorted Over Time Ad Diversified Trading InstituteCombine the QQQ, IWM and SPY in one tradeIf you’ve been investing in the major indexes for the last 20 years, you may need a new strategy. Because the Dow Jones has returned just 349%... The Russell 2000 has returned just 397%... And the S&P 500 has returned just 450%. And although I can’t guarantee results or against losses… I want to tell you about my “2-Click Trade” that has encapsulated more than the return of ALL THREE OF THOSE INDEXES COMBINED… Plus, it targets multiple overnight payouts in a month with 84.3% accuracy! While I cannot promise future returns or against losses…You can find out about this “2-Click Trade” here. Tema Oncology ETF Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/15/20246,500 shares $163,670.00 +195.5%N/A1.2 $25.18 11/30/20242,200 shares $61,208.40 +175.0%N/A0.8 $27.82 11/15/2024800 shares $20,952.00 -20.0%N/A0.3 $26.19 10/31/20241,000 shares $27,621.20 -37.5%N/A0.3 $27.62 10/15/20241,600 shares $45,712.00 -30.4%N/A0.4 $28.57 9/30/20242,300 shares $65,343.00 +283.3%N/A0.5 $28.41 9/15/2024600 shares $17,544.00 +50.0%N/A0.1 $29.24 8/31/2024400 shares $11,948.00 -87.9%N/A0 $29.87 8/15/20243,300 shares $94,677.00 -17.5%N/A0.2 $28.69 7/31/20244,000 shares $117,480.00 -80.7%N/A0.2 $29.37 7/15/202420,700 shares $607,752.00 No ChangeN/A1.2 $29.36 CANC Short Interest - Frequently Asked Questions What is Tema Oncology ETF's current short interest? Short interest is the volume of Tema Oncology ETF shares that have been sold short but have not yet been covered or closed out. As of December 15th, investors have sold 6,500 shares of CANC short. Learn More on Tema Oncology ETF's current short interest. What is a good short interest ratio for Tema Oncology ETF? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CANC shares currently have a short interest ratio of 1.0. Learn More on Tema Oncology ETF's short interest ratio. Is Tema Oncology ETF's short interest increasing or decreasing? Tema Oncology ETF saw a increase in short interest in December. As of December 15th, there was short interest totaling 6,500 shares, an increase of 195.5% from the previous total of 2,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Tema Oncology ETF's short interest compare to its competitors? Here is how the short interest of companies compare to Tema Oncology ETF: Tradr 2X Short Innovation Daily ETF (18.51%), Procure Space ETF (12.36%), AOT Growth & Innovation ETF (0.04%), Global X E-Commerce ETF (0.11%), Fidelity Disruptive Medicine ETF (0.52%), Democratic Large Cap Core ETF (1.53%), Roundhill GLP-1 & Weight Loss ETF (0.46%), Spear Alpha ETF (0.27%), Global X Telemedicine & Digital Health ETF (0.25%), First Trust Dow Jones International Internet ETF (2.37%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.32 billion), Spotify Technology S.A. ($4.06 billion), Canadian Natural Resources Limited ($3.45 billion), Reddit, Inc. ($2.79 billion), International Paper ($2.70 billion), Cencora, Inc. ($2.27 billion), SoFi Technologies, Inc. ($2.21 billion), Lululemon Athletica Inc. ($2.13 billion), and Rivian Automotive, Inc. ($2.05 billion). View all of the most shorted stocks. What does it mean to sell short Tema Oncology ETF stock? Short selling CANC is an investing strategy that aims to generate trading profit from Tema Oncology ETF as its price is falling. CANC shares are trading up $0.38 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Tema Oncology ETF? A short squeeze for Tema Oncology ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CANC, which in turn drives the price of the stock up even further. How often is Tema Oncology ETF's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CANC, twice per month. The most recent reporting period available is December, 15 2024. More Short Interest Resources from MarketBeat Related Companies SARK Short Interest Data UFO Short Interest Data AOTG Short Interest Data EBIZ Short Interest Data FMED Short Interest Data DEMZ Short Interest Data OZEM Short Interest Data SPRX Short Interest Data EDOC Short Interest Data FDNI Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CANC) was last updated on 1/7/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk says U.S. government is going bankruptIn 2016, Jeff Brown called Nvidia at a split-adjusted 66 cents. The company just became the world's third $...Brownstone Research | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Oncology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Oncology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.